Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Kochava, Toledano"'
Publikováno v:
Trauma Surgery & Acute Care Open, Vol 9, Iss 1 (2024)
Background Invasive fungal infections in burn victims significantly increase mortality and hospitalization. The effect of fungal burn wound colonization has not been established.Methods All adult patients hospitalized in the intensive care unit (ICU)
Externí odkaz:
https://doaj.org/article/4f48230117eb48f0baec26692d051203
Autor:
Fadi Kharouf, Tali Eviatar, Maya Braun, Elisheva Pokroy-Shapira, Michal Brodavka, Yair Zloof, Nancy Agmon-Levin, Kochava Toledano, Shirly Oren, Merav Lidar, Devy Zisman, Yonit Tavor, Mirit Amit-Vazina, Firas Sabbah, Gabriel S. Breuer, Amir Dagan, Rima Beshara-Garzuzi, Doron Markovits, Muna Elias, Joy Feld, Oshrat Tayer-Shifman, Tal Gazitt, Tatiana Reitblatt, Limor Rubin, Amir Haddad, Sami Giryes, Daphna Paran, Hagit Peleg, Yair Molad, Ori Elkayam, Dror Mevorach, Alexandra Balbir-Gurman, Yolanda Braun-Moscovici
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
ObjectiveWe aimed to characterize the course of COVID-19 in autoimmune inflammatory rheumatic disease (AIIRD) patients in Israel, taking into consideration several remarkable aspects, including the outcomes of the different outbreaks, the effect of v
Externí odkaz:
https://doaj.org/article/238b5623beef475497b30af9ef008335
Autor:
Rula, Daood, Kochava, Toledano, Doron, Markovits, Yonit, Tavor, Samy, Giryes, Katya, Dolnikov, Helani, Jeries, Alexandra, Balbir-Gurman, Yolanda, Braun-Moscovici
Publikováno v:
Clinical and Experimental Rheumatology.
We aimed to assess the efficacy and patient satisfaction of subcutaneous tocilizumab (SC TCZ) in patients previously treated with intravenous tocilizumab (IV TCZ) during the COVID-19 pandemic.We conducted a single-centre retrospective study at the Rh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4a9ddb758277a4b6ddddbb622ff5539
https://doi.org/10.55563/clinexprheumatol/lxfy2v
https://doi.org/10.55563/clinexprheumatol/lxfy2v
Autor:
Yolanda, Braun-Moscovici, Amir, Dagan, Kochava, Toledano, Doron, Markovits, Amer, Saffouri, Rema, Beshara-Garzoz, Muhamad E, Naffaa, Alexander, Rozin, Menahem A, Nahir, Alexandra, Balbir-Gurman
Publikováno v:
Harefuah. 156(7)
High levels of infliximab (IFX) directed antibodies (IFX-Ab) may result in significant reduction in IFX concentration and loss of drug efficacy.To assess the input of measuring serum IFX levels and levels of IFX-Ab in the management of rheumatic dise
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::033716cf7601014ba738aa7843a46ede
https://pubmed.ncbi.nlm.nih.gov/28786280
https://pubmed.ncbi.nlm.nih.gov/28786280
Autor:
Alexandra Balbir-Gurman, Kochava Toledano, Doron Markovits, Ludmila Guralnik, M. A. Nahir, Alexander Rozin, Yolanda Braun-Moscovici, Yonatan Butbul-Aviel
Publikováno v:
Rheumatology International. 33:1495-1504
Rituximab (RTX) is a chimeric anti-CD20 antibody, approved for rheumatoid arthritis (RA) patients who failed anti-Tumor Necrosis Factor therapy. It has been used occasionally for life-threatening autoimmune diseases (AID). We report our center experi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9db0dd15c684021ecc69e8dd822d9e5d
https://doi.org/10.1007/s00296-012-2587-x
https://doi.org/10.1007/s00296-012-2587-x
Autor:
Yolanda, Braun-Moscovici, Doron, Markovits, Alexander, Rozin, Kochava, Toledano, A Menahem, Nahir, Alexandra, Balbir-Gurman
Publikováno v:
The Israel Medical Association journal : IMAJ. 10(4)
Infliximab and etanercept have been included in the Israeli national list of health services since 2002 for rheumatoid arthritis and juvenile idiopathic arthritis, and since 2005 for psoriatic arthritis and ankylosing spondylitis. The regulator (Mini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e40ec0397252d3add8ef3cac73b6e388
https://pubmed.ncbi.nlm.nih.gov/18548981
https://pubmed.ncbi.nlm.nih.gov/18548981